New DNA test could spare thousands from unnecessary thyroid surgery
NCT ID NCT05229341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new DNA-based method to determine whether thyroid nodules are cancerous or benign. Researchers will analyze tissue from needle biopsies of 1,450 adults to see if the test can accurately tell cancer from harmless growths. The goal is to reduce the number of unnecessary surgeries for nodules that look suspicious but are actually not cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate test for thyroid cancer, helping many people avoid unnecessary surgery for harmless nodules.
- What could go wrong
- This is an early-stage diagnostic study, not a treatment trial. The test may not prove accurate enough in practice, and results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID GLAND CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could spot cancers that standard scans overlook
- Blood test may replace needle biopsy for thyroid cancer
- New MRI technique may predict cancer treatment success early
- New PET tracer could spot hidden cancers
- Heat and radiation team up to fight spine cancer
- 2000 volunteers help create a gold standard for cancer blood tests